# Trevi Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Aug 11, 2025

- Company: [Trevi Therapeutics, Inc.](/companies/trvi.md) (CIK 1563880)
- Form: SCHEDULE 13D/A
- Filed: 2025-08-11
- Accepted by EDGAR: Aug 11, 2025, 18:56 ET
- Period: not reported
- Accession: 0001072613-25-000533
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1563880/000107261325000533/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1563880/000107261325000533/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1563880/000107261325000533/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Aug 11, 2025.
Source: SEC EDGAR, the filing index for accession 0001072613-25-000533. Last ingested by Listed: Nov 10, 2026, 03:00 ET. No prices; not investment advice.